Sign In
Buy NVCR
$16.15
+0.330 (+2.09%)
At Close: Jun 03, 2026
3 Growth Stocks to Buy That Have Crashed More Than 60%
10:52am, Friday, 04'th Feb 2022 The Motley Fool
Don't write off these beaten-down stocks.
Avantor, Inc. (AVTR) Q4 Earnings and Revenues Top Estimates
10:45pm, Thursday, 03'rd Feb 2022 Zacks Investment Research
Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 9.09% and 0.19%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Novocure upgraded to buy at Oppenheimer on valuation, growth potential
05:43pm, Wednesday, 02'nd Feb 2022 Seeking Alpha
Oppenheimer has upgraded shares of NovoCure from perform to outperform citing the company current valuation and growth from the release of next-generation arrays mid
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
03:05pm, Wednesday, 02'nd Feb 2022 Benzinga
Upgrades
Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09 in the year-ago quarter. At
3 Healthcare Stocks That Are Too Cheap to Ignore
11:10am, Sunday, 30'th Jan 2022 The Motley Fool
The market's sell-off is creating deals with mouth-watering upside.
Forget Novocure's Big Drop; Focus on the Long Term
12:55pm, Saturday, 29'th Jan 2022 The Motley Fool
This stock could still be a huge winner.
Forget Novocure''s Big Drop; Focus on the Long Term
12:55pm, Saturday, 29'th Jan 2022 The Motley Fool
This stock could still be a huge winner.
Forget Novocure's Big Drop; Focus on the Long Term
07:55am, Saturday, 29'th Jan 2022
This stock could still be a huge winner.
Why Novocure Stock Is Jumping Today
04:43pm, Thursday, 20'th Jan 2022 The Motley Fool
An analyst upgraded the stock to a buy recommendation.
Why Novocure Stock Is Jumping Today
04:43pm, Thursday, 20'th Jan 2022 The Motley Fool
An analyst upgraded the stock to a buy recommendation.
NovoCure surges after Truist upgraded on potential of cancer studies
03:55pm, Thursday, 20'th Jan 2022 Seeking Alpha
NovoCure <> has recorded the biggest intraday gain in over nine months on below-average volume after Truist analyst Gregory Fraser upgraded the oncology-focused healthcare firm to
Why Novocure Stock Is Jumping Today
11:43am, Thursday, 20'th Jan 2022
An analyst upgraded the stock to a buy recommendation.
Cramer''s lightning round: I would buy some Novocure shares
12:02am, Wednesday, 12'th Jan 2022 CNBC
"Mad Money" host Jim Cramer rings the lightning round bell, which means he''s giving his answers to callers'' stock questions at rapid speed.
NovoCure provides Q4 and FY21 prelim revenues, business updates
05:05pm, Monday, 10'th Jan 2022 Seeking Alpha
NovoCure <> reports prelim full year 2021 net revenues of $535 million vs. consensus of $534.06M, up 8% over the prior year and fourth quarter net revenues of $133 million vs
